Gene · 5244
Papers3,400
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,400
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Is ChatGPT 3.5 smarter than Otolaryngology trainees? A comparison study of board style exam questions. | PLoS One | 2024 | 39325705 | PubTator, text mining | PubMed |
| Emerging role of liver-bone axis in osteoporosis. | J Orthop Translat | 2024 | 39290849 | PubTator, text mining | PubMed |
| Genetic issues in ICP. | Obstet Med | 2024 | 39262913 | PubTator, text mining | PubMed |
| Pharmacokinetic Simulation and Area under the Curve Estimation of Drugs Subject to Enterohepatic Circulation. | Pharmaceutics | 2024 | 39204389 | PubTator, text mining | PubMed |
| Odevixibat as an adjunctive treatment for refractory pruritus in rare variants of cholestatic liver disease. | JPGN Rep | 2024 | 39149201 | PubTator, text mining | PubMed |
| The spectrum of novel ABCB11 gene variations in children with progressive familial intrahepatic cholestasis type 2 in Pakistani cohorts. | Sci Rep | 2024 | 39143102 | PubTator, text mining | PubMed |
| ABC transporters involved in respiratory and cholestatic diseases: From rare to very rare monogenic diseases. | Biochem Pharmacol | 2024 | 39111603 | PubTator, text mining | PubMed |
| Abcb4-defect cholangitis mouse model with hydrophobic bile acid composition by in vivo liver-specific gene deletion. | J Lipid Res | 2024 | 39111549 | PubTator, text mining | PubMed |
| Caspases compromise SLU7 and UPF1 stability and NMD activity during hepatocarcinogenesis. | JHEP Rep | 2024 | 39105183 | PubTator, text mining | PubMed |
| Picroside II promotes HSC apoptosis and inhibits the cholestatic liver fibrosis in Mdr2-/- mice by polarizing M1 macrophages and balancing immune responses. | Chin J Nat Med | 2024 | 39059828 | PubTator, text mining | PubMed |
| Identification of new correctors for traffic-defective ABCB4 variants by a high-content screening approach. | Commun Biol | 2024 | 39048674 | PubTator, text mining | PubMed |
| Acute hepatotoxicity of intravenous amiodarone in a Becker muscular dystrophy patient with decompensated heart failing and ABCB4 gene mutation: as assessed for causality using the updated RUCAM. | J Cardiothorac Surg | 2024 | 39044225 | PubTator, text mining | PubMed |
| Peripherally Restricted CB1 Receptor Inverse Agonist JD5037 Treatment Exacerbates Liver Injury in MDR2-Deficient Mice. | Cells | 2024 | 38994954 | PubTator, text mining | PubMed |
| What's new in pediatric genetic cholestatic liver disease: advances in etiology, diagnostics and therapeutic approaches. | Curr Opin Pediatr | 2024 | 38957097 | PubTator, text mining | PubMed |
| [Clinical phenotype and genotype analysis of progressive familial intrahepatic cholestasis type 3 caused by novel ABCB4 gene mutation]. | Zhonghua Er Ke Za Zhi | 2024 | 38955683 | PubTator, text mining | PubMed |
| Low phospholipid-associated cholelithiasis syndrome, a not uncommon cause of biliary problems and hospital admissions. | Rev Esp Enferm Dig | 2024 | 38874003 | PubTator, text mining | PubMed |
| Whole-exome sequencing for genetic diagnosis of idiopathic liver injury in children. | J Cell Mol Med | 2024 | 38864694 | PubTator, text mining | PubMed |
| Magnetic resonance imaging features of progressive familial intrahepatic cholestasis type 3. | Radiologie (Heidelb) | 2024 | 38829428 | PubTator, text mining | PubMed |
| Making assessment a team sport: a qualitative study of facilitated group feedback in internal medicine residency. | Can Med Educ J | 2024 | 38827914 | PubTator, text mining | PubMed |
| Maralixibat in progressive familial intrahepatic cholestasis (MARCH-PFIC): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. | Lancet Gastroenterol Hepatol | 2024 | 38723644 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5244/papers?page=7